367 studies found for:    (human papillomavirus OR hpv) AND (woman OR women OR female)
Show Display Options
Rank Status Study
21 Completed
Has Results
Human Papillomavirus (HPV) Vaccine (Cervarix TM) Efficacy, Immunogenicity & Safety Trial in Adult Japanese Women With GSK Biologicals HPV-16/18 Vaccine
Conditions: Human Papillomavirus (HPV) Infection;   Papillomavirus Vaccines;   Cervical Neoplasia
Interventions: Biological: HPV-16/18 vaccine (Cervarix™);   Biological: Aimmugen™
22 Recruiting Extended Follow-Up of Young Women in Costa Rica Who Received Vaccination Against Human Papillomavirus Types 16 and 18 and Unvaccinated Controls
Conditions: Cervical Neoplasia;   HPV Infections
Intervention:
23 Completed
Has Results
Evaluation of the Immune and Safety Response of GlaxoSmithKline (GSK) Biologicals' HPV Vaccine in Healthy Indian Women
Conditions: Cervical Cancer;   Papillomavirus Infection
Interventions: Biological: Placebo;   Biological: HPV-16/18 VLP/AS04 Vaccine (Cervarix TM)
24 Completed
Has Results
Immunogenicity and Safety of GlaxoSmithKline Biologicals' Huma Papillomavirus (HPV) Vaccine 580299 in Healthy Females 15 - 25 Years of Age
Condition: HPV-16/18 Infections and Cervical Neoplasia
Intervention: Biological: Cervarix TM
25 Completed
Has Results
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
Conditions: HIV Infections;   Sexually Transmitted Diseases
Intervention: Biological: Quadrivalent HPV vaccine
26 Completed
Has Results
Immunogenicity and Safety of GSK Biologicals' HPV Vaccine 580299 in Healthy Japanese Females 10-15 Years of Age
Condition: Papillomavirus Vaccines
Intervention: Biological: Cervarix™ (HPV-16/18 L1 VLP AS04)
27 Recruiting Genital HPV Infections Before and After Renal Transplantation
Condition: Human Papillomavirus Infections
Intervention:
28 Completed Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention
Conditions: Uterine Cervical Neoplasms;   Uterine Cervical Dysplasia
Intervention: Other: Screening test
29 Completed Human Papilloma Virus Vaccine Safety and Immunogenicity Trial in Young Adolescent Women With GSK Bio HPV-16/18.
Conditions: Human Papillomavirus (HPV) Infection;   Cervical Neoplasia
Intervention: Biological: HPV-16/18 L1/AS04
30 Completed Human Papilloma Virus Vaccine Consistency and Non-inferiority Trial in Young Adult Women With GSK Bio HPV-16/18
Conditions: Human Papillomavirus (HPV) Infection;   Cervical Neoplasia
Intervention: Biological: HPV-16/18 L1/AS04
31 Completed
Has Results
Study to Evaluate the Immune Response and Safety of GSK Biologicals' HPV Vaccine in Healthy Women Aged 18-35 Years
Conditions: Human Papillomavirus (HPV) Infection;   Associated Cervical Neoplasia;   Papillomavirus Vaccines
Interventions: Biological: Placebo;   Biological: HPV-16/18 L1 VLP AS04 (Cervarix TM)
32 Completed Human Papilloma Virus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Bio's Novel HPV Vaccine.
Conditions: Human Papillomavirus (HPV) Infection;   Cervical Neoplasia
Intervention: Biological: Novel HPV vaccine
33 Completed
Has Results
Follow-up Study to Evaluate the Long-term Efficacy of the HPV Vaccine (580299) in Healthy Young Adult Women in Brazil
Conditions: HPV-16/18 Infections;   Cervical Neoplasia
Interventions: Procedure: Blood sampling;   Procedure: Collection of cervical specimen
34 Completed The Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in HIV-Infected Women
Conditions: HIV Infections;   Papilloma
Intervention:
35 Completed
Has Results
Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older
Condition: Infections, Papillomavirus
Interventions: Biological: Cervarix;   Biological: Placebo control
36 Completed
Has Results
Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV Vaccine 580299 in Healthy Females 10 - 25 Years of Age.
Conditions: HPV-16/18 Infections;   Cervical Neoplasia
Interventions: Biological: CervarixTM;   Biological: Placebo vaccine (Al(OH)3)
37 Unknown  Antibody Response to Human Papillomavirus Recombinant Vaccine (Gardasil®) in Girls and Young Women With Chronic Kidney Disease
Condition: Chronic Kidney Disease
Intervention: Drug: Gardasil® Vaccine (FDA-approved vaccination regimen)
38 Completed
Has Results
Immunogenicity and Safety Study of GSK Biologicals' Human Papillomavirus 580299 Vaccine in Healthy Female Subjects
Condition: HPV-16/18 Infections.
Interventions: Biological: CervarixTM;   Other: Control
39 Completed Prevalence, Persistence, and Risk Factors for Oral Human Papillomavirus (HPV) Infections in College Women
Condition: Human Papillomavirus
Intervention:
40 Recruiting Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females
Condition: Infections, Papillomavirus
Interventions: Biological: GSK Biologicals' HPV vaccine 580299;   Biological: Merck's Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years